Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | P10 |
Synonyms | |
Therapy Description |
P10 is a pyridazine derivative that inhibits PARP1 activity, which may result in inhibition of cell proliferation and cell-cycle arrest and leads to enhanced activity when combined with an HDAC inhibitor (PMID: 27188390). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
P10 | PARP-1 Inhibitor 10 | P10 is a pyridazine derivative that inhibits PARP1 activity, which may result in inhibition of cell proliferation and cell-cycle arrest and leads to enhanced activity when combined with an HDAC inhibitor (PMID: 27188390). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|